| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Multidisciplinary Approach in Pharmacovigilance Awareness: ISoP Egypt Chapter’s MedSafetyWeek Experience
|
Rostom, Hadir
|
|
|
44 |
10 |
p. 1017-1020
|
article
|
| 2 |
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
|
Day, John W.
|
|
|
44 |
10 |
p. 1109-1119
|
article
|
| 3 |
Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review
|
Alruqayb, Wadia S.
|
|
|
44 |
10 |
p. 1041-1058
|
article
|
| 4 |
Eritrean Pharmacovigilance System: Key Strategies, Success Stories, Challenges and Lessons Learned
|
Russom, Mulugeta
|
|
|
44 |
10 |
p. 1021-1032
|
article
|
| 5 |
Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
|
de Vries, Sieta T.
|
|
|
44 |
10 |
p. 1073-1083
|
article
|
| 6 |
Patient Global Impression of Benefit–Risk (PGI-BR): Incorporating Patients’ Views of Clinical Benefit–Risk into Assessment of New Medicines
|
Eek, Daniel
|
|
|
44 |
10 |
p. 1059-1072
|
article
|
| 7 |
Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience
|
Magalhães, Luís M.
|
|
|
44 |
10 |
p. 1099-1107
|
article
|
| 8 |
Smart Safety Surveillance (3S): Multi-Country Experience of Implementing the 3S Concepts and Principles
|
Iessa, Noha
|
|
|
44 |
10 |
p. 1085-1098
|
article
|
| 9 |
Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent
|
Okoli, Grace N.
|
|
|
44 |
10 |
p. 1033-1040
|
article
|
Journal description